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Change of Venue
Taking Environmental
Mutagen Research to the
Developing World
The health of a nation could be said to
depend upon the public health expertise of
its scientists. In the United States and other
developed areas of the world, it can be fairly
simple to gain access to a variety of useful
public health resources. But populations liv-
ing in less-developed areas of the world often
lack such knowledge and public health
access. In 1987, two young scientists,
William Au of the University of Texas
Medical Branch (UTMB) and Wagida
Anwar of Ain Shams University in Cairo,
Egypt, decided to seek ways to raise the level
of access to information and technical exper-
tise regarding environmental health dispari-
ties in less-developed regions. 
With a main goal of encouraging collab-
orations for growth of scientific knowledge
and expertise as well as clinical applications
in underserved areas, they focused on orga-
nizing an international conference highlight-
ing the latest research and information on
environmental mutagens. The fruit of that
labor, the International Conference on
Environmental Mutagens in Human
Populations (ICEMHP) series, has become a
boon to the scientific community in devel-
oping nations. The next conference, spon-
sored in part by the NIEHS, is scheduled for
May 2007 in Antalya, Turkey. 
NIEHS scientist Mike Waters, chairman
of the ICEMHP International Advisory
Board, says the institute has been a key par-
ticipant in the conference series since its
inception, noting that institute scientists
have helped with organizing activities, and
that NIEHS leaders have contributed per-
sonal and financial support. He also points
out that the proceedings of the first two con-
ferences were published in the October 1993
and May 1996 issues of EHP Supplements. 
According to Waters, the mission of the
NIEHS lends itself to sponsorship of the
ICEMHP series. “[The NIEHS] fosters
national as well as international efforts to
reduce the burden of environmentally asso-
ciated disease,” he explains. “This series of
conferences certainly has the same objec-
tive. It represents an effective means of
communicating and extending the NIEHS
mission and its research findings to the
developing world.”
Other past and current sponsors for the
conference series include the U.S. CDC,
Novartis Pharmaceutical Company, the
U.S. Environmental Mutagen Society, the
European Environmental Mutagen Society,
the International Association of Environ-
mental Mutagen Societies, the Turkish
Society of Toxicology, Research Corpor-
ation, and the UTMB Department of
Preventive Medicine and Community
Health and Sealy Center for Environmental
Health and Medicine.
Accessible Science
In recalling the impetus for initiating the
first conference, Au reflects, “If you like
your work, you think about what else you
can do to make a difference, so we were
looking for what we could do to have an
impact. We recognized that major confer-
ences were held in developed countries, and
we thought: why not replicate this in other
regions with a need for environmental
health outreach?” 
With encouragement and support from
their mentor, the late Frits Sobels of the
University of Leiden, the Netherlands, the
two young scientists saw the successful stag-
ing of the first ICEMHP in Anwar’s home-
town of Cairo in January 1992. The Cairo
conference was a noted success, with more
than 200 attendees participating in sym-
posia, oral presentations, poster sessions, and
workshops. Following this conference, the
Pan African Environmental Mutagen
Society was formed, and Anwar was later
named Egypt’s assistant minister of health. 
The accomplishments of this first meet-
ing paved the way for the development of
more ICEMHP conferences. Subsequent
meetings have been conducted in Prague,
Czech Republic (1995), Bangkok and Khao
Yai, Thailand (1998), and Florianopolis,
Brazil (2003), with each stimulating public
health programs and collaborations in the
host regions. Au, who has remained the dri-
ving force behind the conferences, collabo-
rates with scientists native to each region
when organizing the proceedings, and gives
priority to locations where the field of envi-
ronmental mutagenesis is still in the devel-
opmental stages. He says one of the main
goals in choosing each location is to make
the opportunity for the exchange of scientif-
ic information available to more people, par-
ticularly those such as students in developing
areas of the world, who might not have the
means to fly to cities across the globe where
major conferences are usually held. 
Students, researchers, practicing clini-
cians, and each host country’s Ministry of
Health are among the regular invitees to
each ICEMHP. Students in particular are
actively recruited; they are offered reduced
registration fees, and are provided with
copies of ICEMHP monographs they might
not otherwise be able to afford––mono-
graphs containing valuable environmental
health information they can consult as they
develop strategies for positive impacts on
health in their home regions. 
Radim S ˇrám, director of the Laboratory
of Genetic Ecotoxicology at the Institute of
Experimental Medicine in Prague, Czech
Republic and co-organizer of the 1995
ICEMHP, sees the meetings as ideal plat-
forms for the exchange of environmental
health information to effect change in each
participant’s home region. “Organizers try to
bring to these meetings young scientists
from developing countries, to stimulate their
interest in the topics to be used in their
countries. . . . These conferences become a
friendly forum to understand the level of sci-
ence in different regions as well as the differ-
ences among the exposure to carcinogens in
different countries.” This information, he
says, “may be later used for regulatory
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Antalya, Turkeychanges.” He also notes that conference
activities always highlight the latest environ-
mental mutagen research, including infor-
mation on new methods and biomarkers for
human studies, and how they should be
processed and interpreted.
A Rewarding Challenge
Although organizers encounter a variety of
issues unique to less-developed areas of the
world during the planning years between
each conference, they are usually able to
work around these challenges. The confer-
ences have had a steady increase in the rate
of attendance over time, even though they
have taken place during politically, socially,
and economically challenging times. For
example, the 2003 conference in Brazil had
a record attendance of more than 600 indi-
viduals despite occurring during a time of
turmoil in the Latin American financial mar-
ket and at the height of worldwide concern
about sudden acute respiratory syndrome
and the risks of international travel. 
The conference budget also presents its
own challenge. Unlike most established con-
ferences, which are sponsored by profession-
al organizations and societies, each
ICEMHP depends wholly upon its organiz-
ers in seeking financial support. Invited
speakers help defray some of the costs by
paying their own travel expenses. Organizers
have also received funding from outside
sponsors such as individual environmental
health experts and entities who see the
intrinsic value in supporting the meetings. 
With four successful conferences behind
him and the May 2007 conference coming
up soon, Au is looking ahead to the contin-
ued fostering of sustainable programs and
initiatives on the local level in developing
countries. Locating the conferences in less-
developed regions remains the cornerstone:
ensuring that young scientists in developing
regions have access to current thinking not
only helps them improve their own knowl-
edge and technical skills, but also fosters a
new generation of environmental health pol-
icy makers, says Au. 
Furthermore, each meeting to date has
helped forge collaborative efforts that have
stimulated the development of local envi-
ronmental mutagen societies and projects
dedicated to improving local environmen-
tal health over the long term. Au says that
connecting with environmental health
decision makers in underserved areas to
determine and address important regional
issues will continue to help shape the
ICEMHP series. –Tanya Tillett
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Headliners Neurodegenerative Disease
NIEHS-Supported Research
Inflammatory Enzyme Modulates Motor Neuron Damage in
Amyotrophic Lateral Sclerosis
Wu DC, Ré DB, Nagai M, Ischiropoulos H, Przedborski S. 2006. The inflammatory NADPH
oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis
mice. Proc Natl Acad Sci U S A 103:12132–12137.
Approximately 30,000 patients in the United States currently have amyotrophic
lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive
neuromuscular disease that weakens and eventually destroys motor neurons
that connect the brain with the skeletal muscles. NIEHS grantee Serge
Przedborski of Columbia University has pioneered the investigation of the mol-
ecular mechanisms leading to the death of neurons that occurs in ALS and
Parkinson disease. Now Przedborski and colleagues provide new insights into
the role of the enzyme NADPH oxidase in the death of motor neurons as a
result of ALS.  
ALS, the most common adult-onset paralytic disease, is most commonly diag-
nosed in middle age, and affects men more often than women. Patients gradu-
ally lose the ability to speak, swallow, and move voluntarily. Sensory function
and intellectual ability are unaffected, and death usually results from loss of res-
piratory function. The disease affects all racial, socioeconomic, and ethnic
groups, and the life expectancy of ALS patients is usually three to five years
after diagnosis.
In this study, the investigators observed spinal cord tissue using a mouse histo-
chemistry model, and created a timeline chronicling observed motor abnormality
behavior in transgenic SOD1G93A mice. They also conducted histological evalua-
tions of postmortem human tissue using a control group and an ALS group.
The researchers discovered that the NADPH oxidase enzyme, an important
component in the generation of destructive reactive oxygen species during
inflammation, is active in the spinal cords of ALS patients and also in the mouse
model of the disease. When they inactivated the enzyme in the mice, they found
that neurodegeneration was significantly delayed, and the mice lived longer.
Additional studies also showed that NADPH oxidase–derived oxidative products
also damaged proteins including insulin-like growth factor 1 receptors located on
motor neurons. 
Insulin-like growth factor 1 has been demonstrated to have therapeutic
potential in ALS patients. The authors conclude that these results suggest that
coadministration of an antiinflammatory agent with the protein may improve
its efficacy in ALS patients. –Jerry Phelps For More Information
http://www.environmutagen2007.org/